NCT00404573View on ClinicalTrials.gov

Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

RGH-188

Trial Locations (1)

63045

For information regarding investigative sites, contact Forest Professional Affairs, St Louis

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY